Indication for Rose Hip, Collagen Peptide, Sodium Hyaluronate, and Vitamin C Combination Tablet
This combination tablet is marketed as a dietary supplement for skin health and anti-aging, specifically targeting skin hydration, elasticity, wrinkle reduction, and overall skin appearance—NOT for osteoarthritis treatment.
Primary Indication: Dermatological/Cosmetic Use
The formulation combines ingredients studied for skin health benefits:
Individual Component Evidence
Rose Hip (275 mg):
- Contains high levels of vitamin C and bioactive compounds
- Studied for wound healing, collagen synthesis, and anti-aging effects 1
- Traditional use in skincare for scarring, hyperpigmentation, and wrinkles
- Exhibits antioxidant and antimicrobial properties against skin bacteria
Collagen Peptide (40 mg):
- Multiple randomized controlled trials demonstrate efficacy for skin parameters 2, 3, 4
- Improves skin hydration, elasticity, roughness, and density when supplemented at 2.5-5g daily 3
- The 40mg dose in this formulation is substantially lower than evidence-based doses (typically 2,500-5,000mg daily)
- Effects include wrinkle reduction and improved skin texture 5, 4
Sodium Hyaluronate (30 mg):
- When combined with collagen and vitamin C, one study showed benefits for dermis density and skin texture 2
- However, the same study found no superior effects when hyaluronic acid was added to collagen alone 2
- The oral bioavailability and efficacy at this low dose (30mg) lacks robust evidence
Vitamin C (33.33 mg):
- Essential for collagen synthesis
- Combined with collagen peptides shows synergistic effects on collagen deposition and expression 6
- The dose provided (33.33mg) is below the typical supplementation range (80-100mg) used in skin studies 2, 3
Critical Limitations
Dosing Concerns:
- The collagen peptide dose (40mg) is 60-125 times lower than evidence-based doses (2,500-5,000mg)
- Vitamin C dose is suboptimal compared to studied formulations
- No clinical trials exist for this specific combination at these doses
NOT Indicated for Osteoarthritis:
Major guidelines explicitly recommend AGAINST these ingredients for OA:
- NICE guidelines (2008): "The use of glucosamine and chondroitin products is not recommended" and "intra-articular hyaluronan injections are not recommended" 7
- EULAR guidelines (2005): Hyaluronic acid and similar agents have "small effect sizes, suitable patients are not well defined" 8
- ACR/Arthritis Foundation (2020): Strongly recommends AGAINST chondroitin sulfate and conditionally recommends AGAINST intraarticular hyaluronic acid for knee/hip OA 9
Clinical Bottom Line
This product is a cosmetic/nutraceutical supplement intended for skin health support, not a therapeutic agent for joint disease. The evidence base supports skin-related benefits for the individual ingredients when used at higher doses than provided in this formulation. Patients seeking joint health benefits should be redirected to evidence-based OA treatments including exercise, weight management, paracetamol, and NSAIDs 7, 10, 9.
Common Pitfall: Patients may confuse this with joint health supplements due to the presence of collagen and hyaluronate. Clarify that oral collagen peptides for skin differ fundamentally from joint cartilage support, and current evidence does not support oral supplementation for OA management.